4,4'-(2,2-Diphenylethene-1,1-diyl)dibenzonitrile

Catalog No. :
ACDQLG158
CAS No. :
2323541-78-0
Molecular Formula :
C28H18N2
Molecular Weight :
382.47

IUPAC Name:4,4'-(2,2-diphenylethene-1,1-diyl)dibenzonitrile

4,4'-(2,2-Diphenylethene-1,1-diyl)dibenzonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$60.00Login to see priceIn stockInquiry
5g98%$222.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,4'-(2,2-Diphenylethene-1,1-diyl)dibenzonitrile
IUPAC Name4,4'-(2,2-diphenylethene-1,1-diyl)dibenzonitrile
Molecular FormulaC28H18N2
Molecular Weight382.47
SMILESN#CC1=CC=C(/C(C2=CC=C(C=C2)C#N)=C(C3=CC=CC=C3)/C4=CC=CC=C4)C=C1
InChI KeyDPLPIRSOTGOWHR-UHFFFAOYSA-N
Synonym1,1'-Bis(4-cyanophenyl)-2,2-diphenylethylene;4,4'-(2,2-Diphenylethene-1,1-diyl)dibenzonitrile;1,1-di(4-cyanophenyl)-2, 2-diphenylethene;1,1'-Bis(4'-cyanophenyl)-2,2-diphenylethylene;Benzonitrile, 4,4′-(2,2-diphenylethenylidene)bis-
CAS No.2323541-78-0
PubChem CID146430658

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACDQLG158 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWQAO289 route compound structure diagram
    ACWQAO28932446-66-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDQLG158 route product structure diagram
    ACDQLG1582323541-78-0 In Stock
Inquiry

2. ACDQLG158 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHYWT941 route compound structure diagram
    ACHYWT941126747-14-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDQLG158 route product structure diagram
    ACDQLG1582323541-78-0 In Stock
Inquiry

Comments (0)